NuScale Power Corporation stocks have been trading down by -7.17 percent following reports of heightened financial instability and project uncertainty.
Click Here for a Millionaire's POV on Trading SMR
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- UBS cut NuScale Power to Sell from Neutral and slashed its price target to $6, flagging shrinking first-mover advantage in small modular reactors and heavy expected cash burn.
- The downgrade and bearish outlook knocked SMR shares down roughly 16% as traders rapidly repriced risk.
- Pomerantz LLP opened a probe into NuScale Power for potential securities fraud or other unlawful practices after the UBS call and sharp stock slide.
- UBS now projects about $700M in negative free cash flow from 2026–2028, highlighting serious funding pressure.
- Legal scrutiny and stalled flagship projects add headline, execution, and reputational risk around SMR’s long-term story.
Live Update At 12:32:31 EDT: On Wednesday, October 07, 2026 NuScale Power Corporation stock [NYSE: SMR] is trending down by -7.17%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
SMR is trading like a classic story stock under pressure. Over the past few weeks, NuScale Power has bled lower from the high $8s to around $7.44 on 2026/10/07. That may not look huge in dollars, but for short-term traders it signals a clear shift in control from buyers to sellers.
The daily chart shows a steady series of lower highs since mid-September. Each bounce in SMR toward $8–$9 has been sold into, and the latest leg down accelerates after the UBS downgrade. On the intraday tape, today’s action around $7.40–$7.60 is tight and sluggish, which tells traders the market is digesting bad news rather than aggressively buying a reversal.
More Breaking News
- BURU Stock Holds Key Level As Traders Eye Mystery 8-K
- LPCN Stock Jumps As BLOOM Phase 3 Trial Kicks Off
- MSTR Stock Extends Surge As Momentum Trading Heats Up
- MTEN Stock Draws Trader Focus As Tight Range Meets Volatility
Fundamentals reinforce the caution. NuScale Power’s latest report shows just $31.5M in revenue against massive losses and negative cash flow. Profit margins are deeply negative, and key ratios like return on equity and return on assets sit well below zero. Yes, SMR has a big cash pile and almost no debt, but with an enterprise value near $2.49B and a price-to-sales ratio above 300, traders are paying a steep premium for a business that is still burning cash heavily.
Why Traders Are Watching SMR’s Legal And Cash Burn Risks
NuScale Power is now a battleground name. The initial blow came when UBS cut SMR from Neutral to Sell and chopped its price target from $10 to $6. That is not a mild tweak; that is a full re-rating of NuScale’s prospects. UBS essentially told the market that SMR’s early edge in small modular reactors has faded, while its project pipeline remains slow and thin.
Traders listened. The downgrade and its harsh language knocked NuScale Power down about 16% as funds rushed to de-risk. A price cut of that size often becomes a magnet on the chart. When a major firm plants a $6 target under a $7–$8 stock, many short-term traders will lean short into any bounce, betting the crowd eventually tests that level.
The story got worse when Pomerantz LLP, a well-known class-action firm, announced an investigation into SMR for potential securities fraud and other unlawful practices. The law firm is focused on the same pressure points UBS flagged: lost first-mover advantage, weak customer commitments, long build timelines, stalled flagship projects, and an estimated $700M in negative free cash flow from 2026–2028.
For traders, that combination is toxic. NuScale Power is capital-intensive, revenue-light, and years away from meaningful cash generation, yet SMR still carries a rich valuation. Add headline risk from a securities-fraud probe, and many large players will simply step aside. That can leave the stock in the hands of fast money, which amplifies volatility and makes SMR a pure trading vehicle rather than a quiet long-term hold.
Conclusion
Right now, NuScale Power is a case study in what happens when a high-expectation story hits a wall. UBS ripped off the bandage by downgrading SMR to Sell, slashing the target to $6, and spelling out structural worries: eroding competitive edge, thin customer traction, and huge cash burn. Pomerantz LLP then stepped in, opening a securities-fraud investigation that layers legal uncertainty on top of already weak sentiment.
The financials back up the cautious stance. SMR has more than $700M in cash and short-term investments, a sky-high current ratio, and no real debt, but it is still losing over $50M a quarter with barely any revenue. UBS’s call for roughly $700M in negative free cash flow from 2026–2028 tells traders the funding story is far from over. That kind of projected burn forces questions about future dilution, partner cash, or government support.
For active traders, the playbook is to respect the risk and let the chart lead. NuScale Power can still offer sharp bounces on short covering or headline relief, but the primary trend and news flow remain bearish. As Tim Sykes loves to remind his students, “The market doesn’t care about your hopes — only price action and catalysts matter.” That dovetails with the idea that setups must be selective: as Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.”. SMR has both, but right now the catalysts are stacked on the downside, so disciplined risk management is not optional.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.